STD Information Card

Total Page:16

File Type:pdf, Size:1020Kb

STD Information Card 3827 4/04 and anal cancers. anal and permission from the MODOH MODOH the from permission cause of certain types of cervical, penile penile cervical, of types certain of cause *Adapted by NYSDOH with with NYSDOH by *Adapted sometimes causes genital warts. It is a a is It warts. genital causes sometimes be done often. done be child during birth. HPV is a virus that that virus a is HPV birth. during child symptoms. Screening for cancer should should cancer for Screening symptoms. sex. It can also be spread from mother to to mother from spread be also can It sex. by a doctor to monitor and reduce reduce and monitor to doctor a by over 30 types that can be spread through through spread be can that types 30 over No known cure. Warts should be treated treated be should Warts cure. known No There are many types of HPV, including including HPV, of types many are There TREATMENT DEFINITION but may itch. may but anus or mouth. Warts usually don’t hurt, hurt, don’t usually Warts mouth. or anus “warts” “HPV” “warts” Slang: Slang: on or around the penis, scrotum, vagina, vagina, scrotum, penis, the around or on PAPILLOMAVIRUS warts – soft fleshy bumps that vary in size size in vary that bumps fleshy soft – warts Often none. Some types cause genital genital cause types Some none. Often HUMAN SYMPTOMS SYMPTOMS SYPHILIS Primary Stage – Small painless sore (chancre) Slang: “pox”, “bad blood” where organism enters the body (genital, oral or rectal); the sore may be internal and go unnoticed. Secondary Stage – Rash that can involve the palms and soles of feet; swollen lymph glands, fever, and painless sores often found in the mouth. DEFINITION Latent Stage – Patient does not have symptoms. A sexually transmitted disease caused by This stage may last for years. a bacterium known as Treponema Late Stage – If left untreated can cause damage pallidum that may be transmitted to the brain or heart, blindness and/or death. sexually or from mother to child before or TREATMENT at the time of birth (congenital syphilis). Can be cured with antibiotic therapy. SYMPTOMS GONORRHEA Males: Most infected men have symptoms which Slang: “dose” “clap” “drip” can include a milky discharge from the penis, a burning sensation upon urination, and sometimes swollen testicles. Females: Most women have no symptoms. If symptoms are present, there is often a vaginal DEFINITION discharge and/or bleeding; low abdominal pain and/or painful urination. Gonorrhea is a sexually transmitted Male/Female: Rectal: itching, pain and disease that is most common in people discharge with blood or pus. Oral: sore throat, ages 15 to 30; many of those infected swollen glands. with gonorrhea also have chlamydia. Gonorrhea is caused by a bacterium TREATMENT known as Neisseria gonorrhoeae. Curable with antibiotic therapy. If not treated, can cause serious health problems. SYMPTOMS CHLAMYDIA Males: Infected men commonly have no Slang: “the clam” “gooey stuff” symptoms. If symptoms are present, there is often a watery or milky discharge from the penis and a burning sensation upon urination. Females: Infected women usually show no DEFINITION symptoms. If symptoms are present, there is Chlamydia is the most common bacterial most often vaginal discharge and/or bleeding; low abdominal pain and painful urination. sexually transmitted disease in the country. It is caused by a bacterium Male/Female: Rectal: pain, itching and discharge with blood or pus. known as Chlamydia trachomatis and is often without symptoms. Chlamydia is TREATMENT frequently diagnosed in teenagers and Curable with antibiotic therapy. If not treated young adults. can cause serious health problems. .
Recommended publications
  • Reporting of Diseases and Conditions Regulation, Amendment, M.R. 289/2014
    THE PUBLIC HEALTH ACT LOI SUR LA SANTÉ PUBLIQUE (C.C.S.M. c. P210) (c. P210 de la C.P.L.M.) Reporting of Diseases and Conditions Règlement modifiant le Règlement sur la Regulation, amendment déclaration de maladies et d'affections Regulation 289/2014 Règlement 289/2014 Registered December 23, 2014 Date d'enregistrement : le 23 décembre 2014 Manitoba Regulation 37/2009 amended Modification du R.M. 37/2009 1 The Reporting of Diseases and 1 Le présent règlement modifie le Conditions Regulation , Manitoba Règlement sur la déclaration de maladies et Regulation 37/2009, is amended by this d'affections , R.M. 37/2009. regulation. 2 Schedules A and B are replaced with 2 Les annexes A et B sont remplacées Schedules A and B to this regulation. par les annexes A et B du présent règlement. Coming into force Entrée en vigueur 3 This regulation comes into force on 3 Le présent règlement entre en vigueur January 1, 2015, or on the day it is registered le 1 er janvier 2015 ou à la date de son under The Statutes and Regulations Act , enregistrement en vertu de Loi sur les textes whichever is later. législatifs et réglementaires , si cette date est postérieure. December 19, 2014 Minister of Health/La ministre de la Santé, 19 décembre 2014 Sharon Blady 1 SCHEDULE A (Section 1) 1 The following diseases are diseases requiring contact notification in accordance with the disease-specific protocol. Common name Scientific or technical name of disease or its infectious agent Chancroid Haemophilus ducreyi Chlamydia Chlamydia trachomatis (including Lymphogranuloma venereum (LGV) serovars) Gonorrhea Neisseria gonorrhoeae HIV Human immunodeficiency virus Syphilis Treponema pallidum subspecies pallidum Tuberculosis Mycobacterium tuberculosis Mycobacterium africanum Mycobacterium canetti Mycobacterium caprae Mycobacterium microti Mycobacterium pinnipedii Mycobacterium bovis (excluding M.
    [Show full text]
  • Syphilis Staging and Treatment Syphilis Is a Sexually Transmitted Disease (STD) Caused by the Treponema Pallidum Bacterium
    Increasing Early Syphilis Cases in Illinois – Syphilis Staging and Treatment Syphilis is a sexually transmitted disease (STD) caused by the Treponema pallidum bacterium. Syphilis can be separated into four different stages: primary, secondary, early latent, and late latent. Ocular and neurologic involvement may occur during any stage of syphilis. During the incubation period (time from exposure to clinical onset) there are no signs or symptoms of syphilis, and the individual is not infectious. Incubation can last from 10 to 90 days with an average incubation period of 21 days. During this period, the serologic testing for syphilis will be non-reactive but known contacts to early syphilis (that have been exposed within the past 90 days) should be preventatively treated. Syphilis Stages Primary 710 (CDC DX Code) Patient is most infectious Chancre (sore) must be present. It is usually marked by the appearance of a single sore, but multiple sores are common. Chancre appears at the spot where syphilis entered the body and is usually firm, round, small, and painless. The chancre lasts three to six weeks and will heal without treatment. Without medical attention the infection progresses to the secondary stage. Secondary 720 Patient is infectious This stage typically begins with a skin rash and mucous membrane lesions. The rash may manifest as rough, red, or reddish brown spots on the palms of the hands, soles of the feet, and/or torso and extremities. The rash does usually does not cause itching. Rashes associated with secondary syphilis can appear as the chancre is healing or several weeks after the chancre has healed.
    [Show full text]
  • Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting As Cellulitis Kelly L
    Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed DO Lehigh Valley Health Network, [email protected] Nektarios I. Lountzis MD Lehigh Valley Health Network, [email protected] Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine Part of the Dermatology Commons, and the Medical Sciences Commons Published In/Presented At Reed, K., Lountzis, N. (2015, April 24). Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis. Poster presented at: Atlantic Dermatological Conference, Philadelphia, PA. This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact [email protected]. Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed, DO and Nektarios Lountzis, MD Lehigh Valley Health Network, Allentown, Pennsylvania Case Presentation: Discussion: Patient: 83 year-old Hispanic female Cutaneous tuberculosis (CTB) was first described in the literature in 1826 by Laennec and has since been History of Present Illness: The patient presented to the hospital for chest pain and shortness of breath and was treated for an NSTEMI. She was noted reported to manifest in a variety of clinical presentations. The most common cause is infection with the to have redness and swelling involving the right lower extremity she admitted to having for 5 months, which had not responded to multiple courses of antibiotics. She acid-fast bacillus Mycobacterium tuberculosis via either primary exogenous inoculation (direct implantation resided in Puerto Rico but recently moved to the area to be closer to her children.
    [Show full text]
  • Compendium of Measures to Control Chlamydia Psittaci Infection Among
    Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 Author(s): Gary Balsamo, DVM, MPH&TMCo-chair Angela M. Maxted, DVM, MS, PhD, Dipl ACVPM Joanne W. Midla, VMD, MPH, Dipl ACVPM Julia M. Murphy, DVM, MS, Dipl ACVPMCo-chair Ron Wohrle, DVM Thomas M. Edling, DVM, MSpVM, MPH (Pet Industry Joint Advisory Council) Pilar H. Fish, DVM (American Association of Zoo Veterinarians) Keven Flammer, DVM, Dipl ABVP (Avian) (Association of Avian Veterinarians) Denise Hyde, PharmD, RP Preeta K. Kutty, MD, MPH Miwako Kobayashi, MD, MPH Bettina Helm, DVM, MPH Brit Oiulfstad, DVM, MPH (Council of State and Territorial Epidemiologists) Branson W. Ritchie, DVM, MS, PhD, Dipl ABVP, Dipl ECZM (Avian) Mary Grace Stobierski, DVM, MPH, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Karen Ehnert, and DVM, MPVM, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Thomas N. Tully JrDVM, MS, Dipl ABVP (Avian), Dipl ECZM (Avian) (Association of Avian Veterinarians) Source: Journal of Avian Medicine and Surgery, 31(3):262-282. Published By: Association of Avian Veterinarians https://doi.org/10.1647/217-265 URL: http://www.bioone.org/doi/full/10.1647/217-265 BioOne (www.bioone.org) is a nonprofit, online aggregation of core research in the biological, ecological, and environmental sciences. BioOne provides a sustainable online platform for over 170 journals and books published by nonprofit societies, associations, museums, institutions, and presses. Your use of this PDF, the BioOne Web site, and all posted and associated content indicates your acceptance of BioOne’s Terms of Use, available at www.bioone.org/page/terms_of_use.
    [Show full text]
  • Pdf/Bookshelf NBK368467.Pdf
    BMJ 2019;365:l4159 doi: 10.1136/bmj.l4159 (Published 28 June 2019) Page 1 of 11 Practice BMJ: first published as 10.1136/bmj.l4159 on 28 June 2019. Downloaded from PRACTICE CLINICAL UPDATES Syphilis OPEN ACCESS Patrick O'Byrne associate professor, nurse practitioner 1 2, Paul MacPherson infectious disease specialist 3 1School of Nursing, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada; 2Sexual Health Clinic, Ottawa Public Health, Ottawa, Ontario K1N 5P9; 3Division of Infectious Diseases, Ottawa Hospital General Campus, Ottawa, Ontario What you need to know Box 1: Symptoms of syphilis by stage of infection (see fig 1) • Incidence rates of syphilis have increased substantially around the Primary world, mostly affecting men who have sex with men and people infected • Symptoms appear 10-90 days (mean 21 days) after exposure with HIV http://www.bmj.com/ • Main symptom is a <2 cm chancre: • Have a high index of suspicion for syphilis in any sexually active patient – Progresses from a macule to papule to ulcer over 7 days with genital lesions or rashes – Painless, solitary, indurated, clean base (98% specific, 31% sensitive) • Primary syphilis classically presents as a single, painless, indurated genital ulcer (chancre), but this presentation is only 31% sensitive; – On glans, corona, labia, fourchette, or perineum lesions can be painful, multiple, and extra-genital – A third are extragenital in men who have sex with men and in women • Diagnosis is usually based on serology, using a combination of treponemal and non-treponemal tests. Syphilis remains sensitive to • Localised painless adenopathy benzathine penicillin G Secondary on 24 September 2021 by guest.
    [Show full text]
  • Nonbacterial Pus-Forming Diseases of the Skin Robert Jackson,* M.D., F.R.C.P[C], Ottawa, Ont
    Nonbacterial pus-forming diseases of the skin Robert Jackson,* m.d., f.r.c.p[c], Ottawa, Ont. Summary: The formation of pus as a Things are not always what they seem Fungus result of an inflammatory response Phaedrus to a bacterial infection is well known. North American blastomycosis, so- Not so well appreciated, however, The purpose of this article is to clarify called deep mycosis, can present with a is the fact that many other nonbacterial the clinical significance of the forma¬ verrucous proliferating and papilloma- agents such as certain fungi, viruses tion of pus in various skin diseases. tous plaque in which can be seen, par- and parasites may provoke pus Usually the presence of pus in or on formation in the skin. Also heat, the skin indicates a bacterial infection. Table I.Causes of nonbacterial topical applications, systemically However, by no means is this always pus-forming skin diseases administered drugs and some injected true. From a diagnostic and therapeutic Fungus materials can do likewise. Numerous point of view it is important that physi¬ skin diseases of unknown etiology cians be aware of the nonbacterial such as pustular acne vulgaris, causes of pus-forming skin diseases. North American blastomycosis pustular psoriasis and pustular A few definitions are required. Pus dermatitis herpetiformis can have is a yellowish [green]-white, opaque, lymphangitic sporotrichosis bacteriologically sterile pustules. The somewhat viscid matter (S.O.E.D.). Pus- cervicofacial actinomycosis importance of considering nonbacterial forming diseases are those in which Intermediate causes of pus-forming conditions of pus can be seen macroscopicaily.
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • 2020 European Guideline on the Management of Syphilis
    DOI: 10.1111/jdv.16946 JEADV GUIDELINES 2020 European guideline on the management of syphilis M. Janier,1,* M. Unemo,2 N. Dupin,3 G.S. Tiplica,4 M. Potocnik, 5 R. Patel6 1STD Clinic, Hopital^ Saint-Louis AP-HP and Hopital^ Saint-Joseph, Paris, France 2WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Orebro€ University Hospital and Orebro€ University, Orebro,€ Sweden 3Syphilis National Reference Center, Hopital^ Tarnier-Cochin, AP-HP, Paris, France 42nd Dermatological Clinic, Carol Davila University, Colentina Clinical Hospital, Bucharest, Romania 5Department of Dermatovenereology, University Medical Centre Ljubljana, Ljubljana, Slovenia 6Department of Genitourinary Medicine, the Royal South Hants Hospital, Southampton, UK *Correspondence to: M. Janier. E-mail: [email protected] Abstract The 2020 edition of the European guideline on the management of syphilis is an update of the 2014 edition. Main modifications and updates include: - The ongoing epidemics of early syphilis in Europe, particularly in men who have sex with men (MSM) - The development of dual treponemal and non-treponemal point-of-care (POC) tests - The progress in non-treponemal test (NTT) automatization - The regular episodic shortage of benzathine penicillin G (BPG) in some European countries - The exclusion of azithromycin as an alternative treatment at any stage of syphilis - The pre-exposure or immediate post-exposure prophylaxis with doxycycline in populations at high risk of acquiring syphilis. Received: 12 June 2020; Accepted: 4 September 2020 Conflicts of interest The authors have no conflicts of interest related to this guideline. Funding sources None. Introduction EEA countries and particularly among men who have sex with Syphilis is a systemic human disease due to Treponema pallidum men (MSM).3 subsp.
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • Treponema Pallidum, the Syphilis Spirochete: Making a Living As a Stealth Pathogen
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Rev Manuscript Author Microbiol. Author Manuscript Author manuscript; available in PMC 2017 June 01. Published in final edited form as: Nat Rev Microbiol. 2016 December ; 14(12): 744–759. doi:10.1038/nrmicro.2016.141. Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen Justin D. Radolf1, Ranjit K. Deka2, Arvind Anand3, David Šmajs4, Michael V. Norgard5, and X. Frank Yang6 1Departments of Medicine, Pediatrics, Genetics and Genomic Science, Molecular Biology and Biophysics, and Immunology, UConn Health, Farmington, CT, USA 2Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA 3Department of Medicine, UConn Health, Farmington, CT, USA 4Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic 5Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA 6Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN Abstract The last two decades have seen a worldwide resurgence in infections caused by Treponema pallidum subsp. pallidum, the syphilis spirochete. The syphilis spirochete’s well-recognized capacity for early dissemination and immune evasion has earned it the designation ‘the stealth pathogen’. Despite the many hurdles to studying syphilis pathogenesis, most notably the inability to culture and to genetically manipulate T. pallidum, in recent years, considerable progress has been made in elucidating the structural, physiologic, and regulatory facets of stealth pathogenicity. In this Review, we integrate this eclectic body of information to garner fresh insights into the highly successful parasitic lifestyles of the syphilis spirochete and related pathogenic treponemes. Pathogenic treponemes cause venereal syphilis, yaws, endemic syphilis, and pinta—multi- stage, infections that, although similar, can be differentiated based on clinical, epidemiologic, and geographic criteria1,2.
    [Show full text]
  • WHO GUIDELINES for the Treatment of Treponema Pallidum (Syphilis)
    WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO Library Cataloguing-in-Publication Data WHO guidelines for the treatment of Treponema pallidum (syphilis). Contents: Web annex D: Evidence profiles and evidence-to-decision frameworks - Web annex E: Systematic reviews for syphilis guidelines - Web annex F: Summary of conflicts of interest 1.Syphilis – drug therapy. 2.Treponema pallidum. 3.Sexually Transmitted Diseases. 4.Guideline. I.World Health Organization. ISBN 978 92 4 154980 6 (NLM classification: WC 170) © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/ copyright_form/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • 3- Chlamydia, Syphilis & Gonorrhea (STD)
    3- Chlamydia, syphilis & gonorrhea (STD) Microbiology 435’s Teamwork Reproductive Block Learning Objectives: ● Know the causative agents of syphilis, gonorrhea and Chlamydia infections. ● Realize that these three infections are acquired through sexual intercourse. ● Know the pathogenesis of syphilis, gonorrhea and Chlamydia infection. ● Describe the clinical feature of the primary, secondary tertiary syphilis and complications. ● Recall the different diagnostic methods for the different stages of syphilis. ● Describe the clinical features of gonorrhea that affect only men, only women and those ones which affect both sexes. ● Describe the different laboratory tests for the diagnosis of gonorrhea ● Describe the morphology and the distinct life cycle of the Chlamydia. ● Realize what are the different genera, species and serotypes of the family Chlamydophila. ● Recognize that Chlamydia cause different diseases that affect the eye (causing trachoma) and the respiratory system (mainly cause a typical pneumonia). ● Know the different urogenital clinical syndromes caused by Chlamydia trachomatis that affect men, women and both sex. ● Realize that these urogenital syndromes are difficult to differentiate clinically from the similar ones caused by N.gonorrheae. ● Know the treatment of syphilis, gonorrhea and Chlamydia infections. ● Realize that there are no effective vaccines against all these three diseases. Important Resources: 435 females & males slides and ​ ​ ​ Males notes notes, wikipedia, ​ ​ Females notes Lippincott’s Illustrated Reviews: Microbiology- ​ ​ Extra Third Edition ​ ​ Editing file: Here ​ ​ Credit: Team members ​ Introduction (take-home message) ● Syphilis, Chlamydia and Gonorrhea are main STDs, caused by delicate organisms that cannot survive ​ ​ ​ outside the body. Infection may not be localized. ​ ​ ● Clinical presentation may be similar (urethral or genital discharge, ulcers). ● One or more organisms (Bacteria, virus, parasite) may be transmitted by sexual contact.
    [Show full text]